表紙:液体栄養補助食品の世界市場 (2021-2026年):産業動向・市場シェア・市場規模・成長予測・成長機会
市場調査レポート
商品コード
1037216

液体栄養補助食品の世界市場 (2021-2026年):産業動向・市場シェア・市場規模・成長予測・成長機会

Liquid Dietary Supplements Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026

出版日: | 発行: IMARC Services Private Limited | ページ情報: 英文 145 Pages | 納期: 2~3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=135.61円
液体栄養補助食品の世界市場 (2021-2026年):産業動向・市場シェア・市場規模・成長予測・成長機会
出版日: 2021年11月10日
発行: IMARC Services Private Limited
ページ情報: 英文 145 Pages
納期: 2~3営業日
  • 全表示
  • 概要
  • 目次
概要

世界の液体栄養補助食品の市場規模は2015年から2020年にかけて緩やかな成長を示し、予測期間中も8%のCAGRで成長すると予測されています。

子供や高齢者の栄養不足が深刻化していることが同市場の成長に影響を与えている大きな要因の一つです。また、慢性疾患の増加や個人の健康意識の高まりなどの要因も市場の成長を促進すると予測されています。

当レポートでは、世界の液体栄養補助食品の市場を調査し、市場概要、市場規模の推移・予測、成分・用途・流通経路・地域/主要国など各種区分別の内訳、競合環境、主要企業のプロファイルなどをまとめています。

目次

第1章 序文

第2章 調査範囲・調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

第5章 世界の液体栄養補助食品市場

  • 市場概要
  • 市場パフォーマンス
  • COVID-19の影響

第6章 市場の内訳:成分別

  • ビタミン・ミネラル
  • 植物成分
  • タンパク質・アミノ酸
  • その他

第7章 市場の内訳:用途別

  • 骨と関節の健康
  • 心臓の健康
  • 免疫の健康
  • スポーツ栄養
  • 減量
  • 消化器の健康
  • その他

第8章 市場の内訳:流通経路別

  • スーパーマーケット・ハイパーマーケット
  • ヘルス&ビューティー小売店
  • ドラッグストア
  • オンラインストア

第9章 市場の内訳:地域別

  • 北米
  • アジア太平洋
  • 欧州
  • ラテンアメリカ
  • 中東・アフリカ

第10章 SWOT分析

第11章 バリューチェーン分析

第12章 ポーターズファイブフォース分析

第13章 価格分析

第14章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Abbott Laboratories
    • Amway(Alticor Global Holdings Inc)
    • Arkopharma
    • BASF SE
    • Bayer AG
    • DuPont de Nemours Inc.
    • Glanbia plc
    • GlaxoSmithKline plc
    • Koninklijke DSM
目次
Product Code: SR1020G237_Report

The global liquid dietary supplements market exhibited moderate growth during 2015-2020. Looking forward, IMARC Group expects the market to grow at a CAGR of 8% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.

Liquid dietary supplements are consumed to increase the nutritional intake, reduce the risk of chronic diseases, promote long-term health and improve the overall quality of life. These supplements are generally available at fitness centers and drug stores, grocery stores, and health food stores in different forms, including soft gels, capsules, tablets, liquid, powders, and gummies. At present, their demand is escalating across the globe on account of the rising consumer inclination towards functional consumables, which are manufactured using natural ingredients.

Liquid Dietary Supplements Market Trends:

The growing prevalence of undernutrition, especially in children and the geriatric population, represents one of the major factors influencing the market growth. Special liquid dietary supplements with extra calories or protein are widely available to satisfy the specific nutritional needs of individuals. Apart from this, several manufacturers are offering liquid dietary supplements for patients receiving dialysis treatments to expand their product portfolio and existing consumer base. Moreover, they are offering products for tube feeding via online distribution channels, which is contributing to market growth. Liquid dietary supplements are also gaining traction as a convenient alternative to solid dosage forms, such as tablets and capsules, for children or individuals with sensitive or irritable digestive systems. These supplements have a pleasant taste and can be added to drinks and food products like juices and cereals. Furthermore, the increasing number of chronic illnesses and the growing health consciousness among individuals are other factors anticipated to bolster the growth of the market.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global liquid dietary supplements market, along with forecasts at the global, regional and country level from 2021-2026. Our report has categorized the market based on region, ingredient, application and distribution channel.

Breakup by Ingredient:

  • Vitamins and Minerals
  • Botanical
  • Proteins and Amino Acids
  • Others

Breakup by Application:

  • Bone and Joint Health
  • Heart Health
  • Immune Health
  • Sports Nutrition
  • Weight Loss
  • Digestive Health
  • Others

Breakup by Distribution Channel:

  • Supermarkets and Hypermarkets
  • Health and Beauty Retail Stores
  • Drug Stores
  • Online Stores

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Amway (Alticor Global Holdings Inc), Arkopharma, BASF SE, Bayer AG, DuPont de Nemours Inc., Glanbia plc, GlaxoSmithKline plc and Koninklijke DSM.

Key Questions Answered in This Report:

  • How has the global liquid dietary supplements market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global liquid dietary supplements market?
  • What are the key regional markets?
  • What is the breakup of the market based on the ingredient?
  • What is the breakup of the market based on the application?
  • What is the breakup of the market based on the distribution channel?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global liquid dietary supplements market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Liquid Dietary Supplements Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Ingredient

  • 6.1 Vitamins and Minerals
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Botanical
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Proteins and Amino Acids
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Others
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Bone and Joint Health
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Heart Health
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Immune Health
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Sports Nutrition
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Weight Loss
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 Digestive Health
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast
  • 7.7 Others
    • 7.7.1 Market Trends
    • 7.7.2 Market Forecast

8 Market Breakup by Distribution Channel

  • 8.1 Supermarkets and Hypermarkets
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Health and Beauty Retail Stores
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Drug Stores
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Online Stores
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Abbott Laboratories
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Amway (Alticor Global Holdings Inc)
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 Arkopharma
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
    • 14.3.4 BASF SE
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Bayer AG
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 DuPont de Nemours Inc.
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Glanbia plc
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
    • 14.3.8 GlaxoSmithKline plc
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Koninklijke DSM
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis